Advertisement

Topics

Bone loss after denosumab, only partial protection with zoledronate

08:08 EDT 2 Aug 2017 | Medical Xpress

Denosumab is a monoclonal antibody which acts as a potent anti-resorptive agent and is now widely used in the treatment of osteoporosis.

Original Article: Bone loss after denosumab, only partial protection with zoledronate

NEXT ARTICLE

More From BioPortfolio on "Bone loss after denosumab, only partial protection with zoledronate"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...